NEO Skin Clinic Ginza Launches "EMFACE", a Non-Incisional Lifting Treatment Targeting Facial Muscles

SBC Medical Group Holdings (Headquarters: California, USA, CEO: Yoshiyuki Aikawa, hereinafter "SBC") is pleased to announce that NEO Skin Clinic Ginza, which it provides management support for, will begin offering "EMFACE", a non-invasive treatment that combines HIFES™ (High-Intensity Focused Electrical Stimulation) and Synchronized RF (Radiofrequency) to simultaneously target facial muscle tightening and skin quality improvement, starting June 9, 2026 (Tuesday).

In recent years, there has been a growing interest in "non-incisional sagging treatments" in aesthetic medicine. Sagging of the face and changes in the facial contour, which become concerns with age, are attributed not only to the decrease in skin elasticity and firmness but also to changes in the facial muscles that support the entire face. Against this backdrop, NEO Skin Clinic Ginza has introduced "EMFACE", a treatment device that focuses on the facial muscles themselves, in addition to conventional approaches to the skin and fat layers. Including combination with existing treatments, we aim to provide more personalized anti-aging care tailored to each customer's concerns and condition.

EMFACE is a non-invasive lifting and skin quality improvement treatment that combines HIFES™ (High-Intensity Focused Electrical Stimulation) and Synchronized RF (Radiofrequency). HIFES™ works on the facial muscles, addressing age-related changes. Synchronized RF delivers thermal energy to the dermis, supporting the production of collagen and elastin, which contributes to maintaining and improving skin firmness and elasticity. By approaching both the skin and facial muscles, it aims to simultaneously improve skin quality and tighten the facial contour. Another feature is that it does not use scalpels or needles, resulting in minimal downtime, and makeup can be applied immediately after the procedure.

For more details about "EMFACE", please click here.

*Side effects (risks) of the procedure: Individual differences may occur in temporary redness (erythema), heat sensation, and feelings similar to muscle pain or fatigue after the procedure. This treatment is a self-pay service and is not covered by public medical insurance.

Comment from Dr. Soichiro Morikawa, Director of NEO Skin Clinic Ginza

In recent years, we have seen an increase in consultations from patients who wish to "maintain a youthful appearance with natural-looking changes." "EMFACE" is a treatment that focuses not only on the skin but also on the facial muscles that support the face. We expect it to be a new option, especially for those concerned about mild to moderate sagging and decreased skin elasticity. Furthermore, its ability to be combined with other device treatments and injectable treatments makes it easier to address a wider range of concerns, which is another key feature. At our clinic, we propose customized treatments while being attentive to each patient's concerns and condition.

For more details on Dr. Morikawa's profile, please click here.

SBC continuously incorporates advanced medical knowledge from Japan and abroad, promoting the improvement of knowledge and technical standards through specialized education. In the rapidly evolving field of aesthetic medicine, we rigorously pursue safety and reproducibility under our unique strict verification system and flexibly introduce new treatments utilizing the latest technologies. Moving forward, we will continue to strive for improvements in safety, transparency, and sustainable value, based on global standards.

SBC Medical Group Holdings

SBC Medical Group Holdings is a Medical Services Organization that provides management support to medical institutions both domestically and internationally across a wide range of medical fields, including aesthetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. With a diverse portfolio of clinic brands, we are also advancing in medical tourism and global expansion into the United States and Asia. Having been listed on the NASDAQ market in the US in September 2024, we were also selected for the "Russell 3000" US stock index in June 2025. Moving forward, we will continue to promote the provision of highly reliable medical services and network expansion to realize our group purpose: "Contributing to the improvement of 'happiness' for people worldwide through medical innovation."

English Name: SBC Medical Group Holdings Incorporated

Stock Exchange: NASDAQ Global Market

Ticker Symbol (US Security Code): SBC

Address: 200 Spectrum Center Drive Suite 300 Irvine, CA 92618 USA

CEO: Yoshiyuki Aikawa

Business: Management support for medical institutions (aesthetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), ophthalmology, etc.)

Official Website: https://sbc-holdings.com

Official LinkedIn Page: https://www.linkedin.com/company/sbc-medical-group-holdings-inc

NEO Skin Clinic: https://www.sbc-neoskinclinic.jp/

[Contact for Inquiries]

SBC Medical Group Holdings

Public Relations Department: Murakami Email: pr@sbc.or.jp

Keywords: